𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study

✍ Scribed by Stephanie Scarmo, Yelena Afanasyeva, Per Lenner, Karen L Koenig…

Book ID
120699081
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
204 KB
Volume
15
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma 25-hydroxyvitamin D and premenopa
Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study
✍ Sascha Abbas; Jenny Chang-Claude; Jakob Linseisen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 2 views

## Abstract Laboratory and epidemiological data have linked vitamin D to breast cancer prevention. Beside dietary intake, endogenous production of vitamin D substantially contributes to a subject's vitamin D status. Most studies, however, have assessed dietary intake only. Although differential eff

Serum levels of vitamin D, PTH and calci
Serum levels of vitamin D, PTH and calcium and breast cancer risk—a prospective nested case–control study
✍ Martin Almquist; Anne-Greth Bondeson; Lennart Bondeson; Johan Malm; Jonas Manjer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 176 KB 👁 2 views

## Abstract Previous studies indicate that calcium and its regulating hormones, __i.e__., parathyroid hormone (PTH) and vitamin D, might affect breast cancer risk. Evidence also suggests that this relationship could be influenced by menopausal status and BMI. We examined breast cancer risk related

Circulating enterolactone and prostate c
Circulating enterolactone and prostate cancer risk: A Nordic nested case-control study
✍ Pär Stattin; Herman Adlercreutz; Leena Tenkanen; Egil Jellum; Sonja Lumme; Göran 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 2 views

## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.